Omada Health director granted 10,882 RSUs

Omada Health, Inc. director Anne Beal received a grant of 10,882 shares of Common Stock in the form of restricted stock units (RSUs).

Rhea-AI Filing Summary

Omada Health, Inc. director Anne Beal received a grant of 10,882 shares of Common Stock in the form of restricted stock units (RSUs). The RSUs have no cash exercise price and will convert into one share of Common Stock per unit when they vest.

According to the award terms, 100% of the RSUs will vest on the earlier of the first anniversary of the grant date or the date of the 2027 Annual Meeting of stockholders, if she continues in service through that date. After this grant, Beal directly holds 20,618 shares of Omada Health common stock.

Insider Trade Summary

Grant/Award: 10,882 shares

Grant/Award 1 txn

Insider Beal Anne

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	10,882	$0.00	$0.00

Holdings After Transaction: Common Stock — 20,618 shares (Direct)

Footnotes (1)

1. F1. Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will fully vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, subject to continued service through such vesting date.

Key Figures

RSU grant size: 10,882 shares Transaction price per share: $0.0000 per share Shares held after grant: 20,618 shares +1 more

4 metrics

RSU grant size 10,882 shares Restricted stock units of Common Stock granted to Anne Beal

Transaction price per share $0.0000 per share RSU award has no cash exercise price

Shares held after grant 20,618 shares Total Omada Health Common Stock directly held by Anne Beal after transaction

Vesting timing First anniversary or 2027 meeting RSUs vest on first anniversary of grant or 2027 Annual Meeting, whichever is earlier

Key Terms

restricted stock units, RSUs, Annual Meeting of the Issuer's stockholders, Grant, award, or other acquisition

4 terms

restricted stock units financial

"Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"100% of the RSUs will fully vest on the earlier of (i) the first anniversary of the grant date"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Annual Meeting of the Issuer's stockholders financial

"or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders"

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Omada Health (OMDA) director Anne Beal report in this Form 4?

Anne Beal reported receiving 10,882 restricted stock units of Omada Health Common Stock as a compensation grant. These RSUs convert to one share each upon vesting, representing a non-cash equity award rather than an open-market stock purchase.

How many Omada Health (OMDA) shares does Anne Beal hold after this RSU grant?

After the RSU grant, Anne Beal holds 20,618 shares of Omada Health Common Stock directly. This total reflects the newly awarded 10,882 restricted stock units, which will settle into shares when they vest under the terms of the award.

What are the vesting terms of Anne Beal’s Omada Health (OMDA) RSU award?

The RSU award vests 100% on the earlier of the first anniversary of the grant date or the date of Omada Health’s 2027 Annual Meeting. Vesting is conditioned on Anne Beal’s continued service with the company through the applicable vesting date.

Does Anne Beal pay a purchase price for the Omada Health (OMDA) RSUs?

No, Anne Beal does not pay a purchase price for these RSUs; the Form 4 lists a transaction price per share of $0.0000. The award is a stock-based compensation grant that converts into common shares upon vesting without additional cash outlay.

Is Anne Beal’s Omada Health (OMDA) transaction an open-market buy or sale?

The filing shows a grant or award acquisition, not an open-market trade. The transaction is coded as “A” for an equity grant, meaning Omada Health granted restricted stock units to Anne Beal as compensation rather than her buying or selling shares in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:20 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Beal Anne

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		A		10,882(1)	A	$0	20,618	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will fully vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, subject to continued service through such vesting date.

	/s/ Nathan Salha, as Attorney-in-Fact for Anne Beal	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)